These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
488 related articles for article (PubMed ID: 31449981)
1. Utility of positron emission tomography/computed tomography (PET/CT) imaging in the evaluation of sarcomas: A systematic review. Lim HJ; Johnny Ong CA; Tan JW; Ching Teo MC Crit Rev Oncol Hematol; 2019 Nov; 143():1-13. PubMed ID: 31449981 [TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
3. Differentiation of soft tissue and bone sarcomas from benign lesions utilizing Chen B; Feng H; Xie J; Li C; Zhang Y; Wang S BMC Med Imaging; 2020 Jul; 20(1):85. PubMed ID: 32711449 [TBL] [Abstract][Full Text] [Related]
4. What Is the Comparative Ability of 18F-FDG PET/CT, 99mTc-MDP Skeletal Scintigraphy, and Whole-body MRI as a Staging Investigation to Detect Skeletal Metastases in Patients with Osteosarcoma and Ewing Sarcoma? Aryal A; Kumar VS; Shamim SA; Gamanagatti S; Khan SA Clin Orthop Relat Res; 2021 Aug; 479(8):1768-1779. PubMed ID: 33635285 [TBL] [Abstract][Full Text] [Related]
5. The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis. Bastiaannet E; Groen H; Jager PL; Cobben DC; van der Graaf WT; Vaalburg W; Hoekstra HJ Cancer Treat Rev; 2004 Feb; 30(1):83-101. PubMed ID: 14766127 [TBL] [Abstract][Full Text] [Related]
7. Utilization of positron emission tomography in the management of patients with sarcoma. Benz MR; Tchekmedyian N; Eilber FC; Federman N; Czernin J; Tap WD Curr Opin Oncol; 2009 Jul; 21(4):345-51. PubMed ID: 19412096 [TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of (18)F-FDG PET at diagnosis in patients with soft tissue sarcoma and bone sarcoma; systematic review and meta-analysis. Kubo T; Furuta T; Johan MP; Ochi M Eur J Cancer; 2016 May; 58():104-11. PubMed ID: 26990930 [TBL] [Abstract][Full Text] [Related]
9. Molecular imaging of sarcomas with FDG PET. Mendoza H; Nosov A; Pandit-Taskar N Skeletal Radiol; 2023 Mar; 52(3):461-475. PubMed ID: 36173459 [TBL] [Abstract][Full Text] [Related]
10. Correlating metabolic activity on 18F-FDG PET/CT with histopathologic characteristics of osseous and soft-tissue sarcomas: a retrospective review of 136 patients. Rakheja R; Makis W; Skamene S; Nahal A; Brimo F; Azoulay L; Assayag J; Turcotte R; Hickeson M AJR Am J Roentgenol; 2012 Jun; 198(6):1409-16. PubMed ID: 22623556 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of Kassem TW; Abdelaziz O; Emad-Eldin S Diagn Interv Imaging; 2017 Oct; 98(10):693-698. PubMed ID: 28734778 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of several FDG PET parameters for prediction of soft tissue tumour grade at primary diagnosis and recurrence. Fendler WP; Chalkidis RP; Ilhan H; Knösel T; Herrmann K; Issels RD; Bartenstein P; Cyran CC; Lindner LH; Hacker M Eur Radiol; 2015 Aug; 25(8):2214-21. PubMed ID: 25693667 [TBL] [Abstract][Full Text] [Related]
13. Performance of Positron Emission Tomography and Positron Emission Tomography/Computed Tomography Using Fluorine-18-Fluorodeoxyglucose for the Diagnosis, Staging, and Recurrence Assessment of Bone Sarcoma: A Systematic Review and Meta-Analysis. Liu F; Zhang Q; Zhu D; Liu F; Li Z; Li J; Wang B; Zhou D; Dong J Medicine (Baltimore); 2015 Sep; 94(36):e1462. PubMed ID: 26356700 [TBL] [Abstract][Full Text] [Related]
14. Value of FDG PET/CT in Patient Management and Outcome of Skeletal and Soft Tissue Sarcomas. Sheikhbahaei S; Marcus C; Hafezi-Nejad N; Taghipour M; Subramaniam RM PET Clin; 2015 Jul; 10(3):375-93. PubMed ID: 26099673 [TBL] [Abstract][Full Text] [Related]
15. Clinical value of [18-F]] fluorodeoxyglucose positron emission tomography imaging in soft tissue sarcomas. Schwarzbach MH; Dimitrakopoulou-Strauss A; Willeke F; Hinz U; Strauss LG; Zhang YM; Mechtersheimer G; Attigah N; Lehnert T; Herfarth C Ann Surg; 2000 Mar; 231(3):380-6. PubMed ID: 10714631 [TBL] [Abstract][Full Text] [Related]
16. Functional image in soft tissue sarcomas: An update of the indications of Rodríguez-Alfonso B; Simó-Perdigó M; Orcajo Rincón J Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(4):233-243. PubMed ID: 32616457 [TBL] [Abstract][Full Text] [Related]
17. The impact of Elmanzalawy A; Vali R; Chavhan GB; Gupta AA; Omarkhail Y; Amirabadi A; Shammas A Pediatr Radiol; 2020 Feb; 50(2):252-260. PubMed ID: 31628508 [TBL] [Abstract][Full Text] [Related]
19. Dual-time point 18FDG-PET/CT imaging may be useful in assessing local recurrent disease in high grade bone and soft tissue sarcoma. Dancheva Z; Bochev P; Chaushev B; Yordanova T; Klisarova A Nucl Med Rev Cent East Eur; 2016; 19(1):22-7. PubMed ID: 26841376 [TBL] [Abstract][Full Text] [Related]
20. Meta-Analysis of the Diagnostic Accuracy of Primary Bone and Soft Tissue Sarcomas by 18F-FDG-PET. Younis MH; Abu-Hijleh HA; Aldahamsheh OO; Abualruz A; Thalib L Med Princ Pract; 2020; 29(5):465-472. PubMed ID: 31887730 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]